{"id":79584,"sourceType":"web_search","title":"Milwaukee Courier, citing lobbying disclosures","url":null,"publication":"Directed Inquiry — Web Search","date":"2025-07-01","entity":{"id":162988,"name":"Dan Todd","slug":"dan-todd"},"custody":{"contentHash":"c4d9642bf9b9c895694b0478fbe5265bea76d3ac8e3ae06c63438e95f22fe70e","contentHashAt":"2026-10-01T09:07:35.579Z","contentLength":206,"capturedAt":"2026-10-01T09:07:35.579Z","hashAlgorithm":"sha256","hashFormula":"sha256(coalesce(url, '<no-url>') || '\\n' || raw_content)","hashEncoding":"hex"},"mediaCitation":null,"preview":"In the period around Steil's OBBB vote, Todd specifically lobbied the House on 'issues related to rare disease and orphan drugs,' 'drug pricing,' and the 'implementation of Inflation Reduction Act of 2022.'","verifyUrl":"/source/79584/verify","htmlReceiptUrl":"/source/79584/receipt","corpusAttestationUrl":"/attestation/latest.json"}